Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice

European Journal of Heart Failure

Volumn 10, Issue 4, 2008, Pages 343-351

  Pons, Sandrine ^a,b   Griol Charhbili, Violaine ^a,b   Heymes, Christophe ^a   Fornes, Paul ^a,b   Heudes, Didier ^a,c   Hagege, Albert ^c,d   Loyer, Xavier ^a   Meneton, Pierre ^a   Giudicelli, Jean François ^b   Samuel, Jane Lise ^a   Alhenc Gelas, François ^a,c   Richer, Christine ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL BROUSSAIS   (France)

Author keywords

Cardiac remodelling; Genetically modified mice; Kallikrein kinin system; Mortality; Myocardial infarction; Nitric oxide synthase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; TISSUE KALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; CORONARY RISK; DISEASE EXACERBATION; ENZYME PHOSPHORYLATION; GENOTYPE; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CAPILLARY; HEART RIGHT VENTRICLE; HEART WEIGHT; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RAT; REGULATORY MECHANISM; SURVIVAL TIME; TISSUE KALLIKREIN DEFICIENCY; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WILD TYPE;

ANIMALS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; KININS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRIC OXIDE SYNTHASE; ORGAN SIZE; STROKE VOLUME; SURVIVAL RATE; TISSUE KALLIKREINS; VENTRICULAR REMODELING;

EID: 41449118473     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.02.002     Document Type: Article

References (30)

1. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
2. Griol-Charhbili V., Messadi-Laribi E., Bascands J.L., et al. Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia. FASEB J 19 (2005) 1172-1174
3. Pinto Y.M., Bader M., Pesquero J.B., et al. Increased kallikrein expression protects against cardiac ischemia. FASEB J 14 (2000) 1861-1863
4. Tschope C., Spillmann F., Altmann C., et al. The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. Cardiovasc Res 61 (2004) 559-569
5. Wollert K.C., Studer R., Doerfer K., et al. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation 95 (1997) 1910-1917
6. Xu J., Carretero O.A., Sun Y., et al. Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension 45 (2005) 1-7
7. Yang X.P., Liu Y.H., Mehta D., et al. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice. Circ Res 88 (2001) 1072-1079
8. Liu Y.H., Yang X.P., Mehta D., Bulagannawar M., Scicli G.M., and Carretero O.A. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. Am J Physiol Heart Circ Physiol 278 (2000) H507-H514
9. Meneton P., Bloch-Faure M., Hagege A.A., et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci U S A 98 (2001) 2634-2639
10. Bergaya S., Meneton P., Bloch-Faure M., et al. Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ Res 88 (2001) 593-599
11. Nolly H., Carbini L.A., Scicli G., Carretero O.A., and Scicli A.G. A local kallikrein-kinin system is present in rat hearts. Hypertension 23 (1994) 919-923
12. Azizi M., Boutouyrie P., Bissery A., et al. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest 115 (2005) 780-787
13. Trabold F., Pons S., Hagege A.A., et al. Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice. Hypertension 40 (2002) 90-95
14. Pons S., Fornes P., Hagege A.A., Heudes D., Giudicelli J.F., and Richer C. Survival, haemodynamics and cardiac remodelling follow up in mice after myocardial infarction. Clin Exp Pharmacol Physiol 30 (2003) 25-31
15. Patten R.D., Aronovitz M.J., Deras-Mejia L., et al. Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol 274 (1998) H1812-H1820
16. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
17. Richer C., Mulder P., Fornes P., Domergue V., Heudes D., and Giudicelli J.F. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats. J Cardiovasc Pharmacol 20 (1992) 147-156
18. Damy T., Ratajczak P., Shah A.M., et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363 (2004) 1365-1367
19. Jenzano J.W., Coffey J.C., Heizer W.D., Lundblad R.L., and Scicli A.G. The assay of glandular kallikrein and prekallikrein in human mixed saliva. Arch Oral Biol 33 (1988) 641-644
20. Michel J.B., Mercadier J.J., Galen F.X., et al. Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats. Cardiovasc Res 24 (1990) 946-952
21. Menard J., and Catt K.J. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 90 (1972) 422-430
22. Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Assoc 58 (1963) 690-700
23. Tomaselli G.F., and Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42 (1999) 270-283
24. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., and Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
25. Torp-Pedersen C., and Kober L. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. Lancet 354 (1999) 9-12
26. Kichuk M.R., Seyedi N., Zhang X., et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 94 (1996) 44-51
27. Agata J., Chao L., and Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension 40 (2002) 653-659
28. Scherrer-Crosbie M., Ullrich R., Bloch K.D., et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104 (2001) 1286-1291
29. Dawson D., Lygate C.A., Zhang M.H., Hulbert K., Neubauer S., and Casadei B. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112 (2005) 3729-3737
30. Slim R., Torremocha F., Moreau T., et al. Loss-of-function polymorphism of the human kallikrein gene with reduced urinary kallikrein activity. J Am Soc Nephrol 13 (2002) 968-976